Metformin XR Half-Life
The plasma elimination half-life of metformin extended-release (XR) is approximately 6.2 hours, identical to immediate-release metformin, while the blood elimination half-life is approximately 17.6 hours due to partitioning into red blood cells 1.
Key Pharmacokinetic Parameters
The half-life of metformin XR does not differ from immediate-release formulations because both contain the same active drug—only the release mechanism differs:
- Plasma half-life: ~6.2 hours
- Blood half-life: ~17.6 hours (reflecting erythrocyte distribution)
- Time to peak concentration (Tmax): 7 hours (median), range 4-8 hours 1
- No drug accumulation: Mean accumulation ratio of 1.0 with repeated dosing 2
Clinical Implications
Renal function is the primary determinant of metformin elimination, as the drug is cleared unchanged through the kidneys via tubular secretion (renal clearance is 3.5 times greater than creatinine clearance) 1:
- Normal renal function: Standard half-life applies
- Impaired renal function: Both plasma and blood half-lives are prolonged, with decreased renal clearance 1
- Severe overdose case: A reported half-life of 33 hours during continuous venovenous hemodiafiltration (CVVHDF) in a massive overdose (80g ingestion) 3
Important Caveats
The extended-release formulation affects absorption kinetics but not elimination kinetics:
- XR achieves peak levels more slowly (7 hours vs 3 hours for IR) 2
- Total drug exposure (AUC) is equivalent between XR and IR formulations 1
- The slower absorption profile allows once-daily dosing and may improve GI tolerability 4
Monitor renal function closely: Metformin should be used cautiously when eGFR is 30-45 mL/min/1.73 m² due to increased risk of lactic acidosis from drug accumulation 4. The prolonged blood half-life (17.6 hours) reflects red blood cell partitioning and explains why metformin effects persist beyond the plasma half-life 1.